RE: Fincapp Broker Note - £75 per share6 Jan 2022 16:18
Great RNS today and as others have noted, why would such a deal be forthcoming unless both parties were very confident in the trial results being good.
On the question of ultimate share value if the trial results prove up SNG001, I would imagine that shareholders would get best value if Synairgen manages to blossom into a sizeable pharma itself, paying dividends. But how likely is that scenario? Not very imv. I think the company would prove irresistible to one of the big pharmas. So the best case would be a bidding battle between 2 or more pharmas.
Time will tell, and the time is now close :D gla